Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico.
Daniel De-la-Rosa-MartinezMercedes Aranda-AudeloAlexandra Martin-OnraetBeda Islas-MuñozCarolina Perez-JimenezPamela Alatorre-FernandezPatricia Cornejo-JuarezErika Ruiz-GarciaPaola Zinser-PenicheLuis Nuñez-LunaAbelardo Meneses-GarciaAngel Herrera-GomezDiana Vilar ComptePublished in: Cancer medicine (2022)
In this study, patients with cancer showed higher mortality, need for hospitalization, and IMV compared with other non-cancer cohorts. We did not find an increased risk in mortality for HM. Although our cohort was younger than others previously reported, age was a strong predictor of adverse outcomes. Variables associated with IMV and death were similar to those previously described in cancer patients with COVID-19.